254 related articles for article (PubMed ID: 23438143)
21. Microneedling as an adjuvant to topical therapies for melasma: A systematic review and meta-analysis.
Bailey AJM; Li HO; Tan MG; Cheng W; Dover JS
J Am Acad Dermatol; 2022 Apr; 86(4):797-810. PubMed ID: 33857549
[TBL] [Abstract][Full Text] [Related]
22. Systemic treatments for melasma: adjuvant therapy with a novel topical agent.
Cohen PR
Int J Dermatol; 2018 Mar; 57(3):e20-e21. PubMed ID: 29313951
[No Abstract] [Full Text] [Related]
23. The stepwise approach to the treatment of melasma.
Perez MI
Cutis; 2005 Apr; 75(4):217-22. PubMed ID: 15916218
[TBL] [Abstract][Full Text] [Related]
24. Safety and efficacy of mesotherapy in the treatment of melasma: A review article.
Khalili M; Amiri R; Iranmanesh B; Zartab H; Aflatoonian M
J Cosmet Dermatol; 2022 Jan; 21(1):118-129. PubMed ID: 34846788
[TBL] [Abstract][Full Text] [Related]
25. Melasma: systematic review of the systemic treatments.
Zhou LL; Baibergenova A
Int J Dermatol; 2017 Sep; 56(9):902-908. PubMed ID: 28239840
[TBL] [Abstract][Full Text] [Related]
26. Comparing the efficacy of Myjet-assisted tranexamic acid and vitamin C in treating melasma: A split-face controlled trial.
Zhao H; Li M; Zhang X; Li L; Yan Y; Wang B
J Cosmet Dermatol; 2020 Jan; 19(1):47-54. PubMed ID: 31479196
[TBL] [Abstract][Full Text] [Related]
27. Roller Microneedle Combined with Tranexamic Acid Solution in Treating Melasma.
Zheng W; Liu S; Tian L; Ke D
J Vis Exp; 2024 Jan; (203):. PubMed ID: 38314835
[TBL] [Abstract][Full Text] [Related]
28. Liposomal azelaic acid 20% cream vs hydroquinone 4% cream as adjuvant to oral tranexamic acid in melasma: a comparative study.
Akl EM
J Dermatolog Treat; 2022 Jun; 33(4):2008-2013. PubMed ID: 33823725
[TBL] [Abstract][Full Text] [Related]
29. Oral tranexamic acid for the treatment of melasma.
Ali FR
Clin Exp Dermatol; 2019 Apr; 44(3):347-349. PubMed ID: 30484898
[No Abstract] [Full Text] [Related]
30. Treatment of melasma with oral administration of tranexamic acid.
Wu S; Shi H; Wu H; Yan S; Guo J; Sun Y; Pan L
Aesthetic Plast Surg; 2012 Aug; 36(4):964-70. PubMed ID: 22552446
[TBL] [Abstract][Full Text] [Related]
31. Dermoscopic evaluation of tranexamic acid versus Vitamin C, with microneedling in the treatment of melasma: a comparative, split-face, single-blinded study.
Tahoun AI; Mostafa WZ; Amer MA
J Dermatolog Treat; 2022 May; 33(3):1623-1629. PubMed ID: 33393842
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of oral tranexemic acid in refractory melasma: A clinico-immuno-histopathological study.
Nagaraju D; Bhattacharjee R; Vinay K; Saikia UN; Parsad D; Kumaran MS
Dermatol Ther; 2018 Sep; 31(5):e12704. PubMed ID: 30253023
[TBL] [Abstract][Full Text] [Related]
33. A pilot study of oral tranexamic acid and Glycyrrhizin compound in the treatment of recalcitrant Riehl's melanosis.
Xu Z; Xing X; Zhang C; Chen L; Flora Xiang L
J Cosmet Dermatol; 2019 Feb; 18(1):286-292. PubMed ID: 30341831
[TBL] [Abstract][Full Text] [Related]
34. Comparing the efficacy of topical hydroquinone 2% versus intradermal tranexamic acid microinjections in treating melasma: a split-face controlled trial.
Saki N; Darayesh M; Heiran A
J Dermatolog Treat; 2018 Jun; 29(4):405-410. PubMed ID: 29027510
[TBL] [Abstract][Full Text] [Related]
35. Successful short-term and long-term treatment of melasma and postinflammatory hyperpigmentation using vitamin C with a full-face iontophoresis mask and a mandelic/malic acid skin care regimen.
Taylor MB; Yanaki JS; Draper DO; Shurtz JC; Coglianese M
J Drugs Dermatol; 2013 Jan; 12(1):45-50. PubMed ID: 23377327
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and possible mechanisms of topical tranexamic acid in melasma.
Kim SJ; Park JY; Shibata T; Fujiwara R; Kang HY
Clin Exp Dermatol; 2016 Jul; 41(5):480-5. PubMed ID: 27135282
[TBL] [Abstract][Full Text] [Related]
37. A randomized, open-label, comparative study of oral tranexamic acid and tranexamic acid microinjections in patients with melasma.
Khurana VK; Misri RR; Agarwal S; Thole AV; Kumar S; Anand T
Indian J Dermatol Venereol Leprol; 2019; 85(1):39-43. PubMed ID: 30333359
[TBL] [Abstract][Full Text] [Related]
38. The optimal dose of oral tranexamic acid in melasma: A network meta-analysis.
Wang WJ; Wu TY; Tu YK; Kuo KL; Tsai CY; Chie WC
Indian J Dermatol Venereol Leprol; 2023; 89(2):189-194. PubMed ID: 36332095
[TBL] [Abstract][Full Text] [Related]
39. The effects of hydroporation on melasma with anti-aging cocktail.
Chae JB; Yang SH; Byun SY; Choi HR; Shin JW; Park KC
J Cosmet Dermatol; 2017 Dec; 16(4):e15-e20. PubMed ID: 28133891
[TBL] [Abstract][Full Text] [Related]
40. Combined trichloroacetic acid peel and topical ascorbic acid versus trichloroacetic acid peel alone in the treatment of melasma: a comparative study.
Soliman MM; Ramadan SA; Bassiouny DA; Abdelmalek M
J Cosmet Dermatol; 2007 Jun; 6(2):89-94. PubMed ID: 17524124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
